
Scientists Find Promise in a New Peptide Drug to Combat a Deadly Brain Cancer
Newswise — A lab-designed molecule developed and extensively studied by scientists with Virginia Tech’s Fralin Biomedical Research Institute at VTC could represent a breakthrough in slowing tumor recurrence in glioblastoma, an aggressive and deadly form of …